- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- L-Pyr-L-Glu-L-Gln-L-Leu-L-Glu-L-Arg-L-Ala-L-Leu-L-Asn-L-Ser-
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
L-Pyr-L-Glu-L-Gln-L-Leu-L-Glu-L-Arg-L-Ala-L-Leu-L-Asn-L-Ser-L-Ser
| EU orphan designation number: | EU/3/16/1721
|
| Active ingredient: | L-Pyr-L-Glu-L-Gln-L-Leu-L-Glu-L-Arg-L-Ala-L-Leu-L-Asn-L-Ser-L-Ser |
| Indication: | Prevention of graft loss in pancreatic islet transplantation |
| Sponsor: | Araim Pharma Europe Ltd
The Coach House, The Square, Sawbridgeworth, Herts CM21 9AE, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 31/08/2016 | Orphan designation | EMA/OD/094/16 | (2016)5628 of 29/08/2016 |
CONTACT
EU links
Directorate General Health & Consumers